1. Villy, Marie-Charlotte, Masliah-Planchon, Julien, Schnitzler, Anne, Bieche, Ivan, Colas, Chrystelle. 2023. MSH3: a confirmed predisposing gene for adenomatous polyposis. In Journal of medical genetics, 60, 1198-1205. doi:10.1136/jmg-2023-109341. https://pubmed.ncbi.nlm.nih.gov/37402566/
2. Xu, Kai, Zhang, Ye, Yan, Zhiwei, Chen, Zhiyuan, Liu, Xiuheng. 2023. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. In Frontiers in immunology, 14, 1205250. doi:10.3389/fimmu.2023.1205250. https://pubmed.ncbi.nlm.nih.gov/37426643/
3. O'Reilly, Daniel, Belgrad, Jillian, Ferguson, Chantal, Aronin, Neil, Khvorova, Anastasia. 2023. Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease. In Molecular therapy : the journal of the American Society of Gene Therapy, 31, 1661-1674. doi:10.1016/j.ymthe.2023.05.006. https://pubmed.ncbi.nlm.nih.gov/37177784/
4. Aldous, Sarah G, Smith, Edward J, Landles, Christian, Greene, Jonathan R, Bates, Gillian P. . A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease. In Brain : a journal of neurology, 147, 1784-1798. doi:10.1093/brain/awae063. https://pubmed.ncbi.nlm.nih.gov/38387080/
5. Rebuzzi, Francesca, Ulivi, Paola, Tedaldi, Gianluca. 2023. Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? In International journal of molecular sciences, 24, . doi:10.3390/ijms24032137. https://pubmed.ncbi.nlm.nih.gov/36768460/
6. Hirata, Hiroshi, Hinoda, Yuji, Kawamoto, Ken, Tanaka, Yuichiro, Dahiya, Rajvir. 2008. Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. In The Journal of urology, 179, 2020-4. doi:10.1016/j.juro.2008.01.009. https://pubmed.ncbi.nlm.nih.gov/18355840/
7. Driscoll, Rachelle, Hampton, Lucas, Abraham, Neeta A, Gallant-Behm, Corrie L, Weihofen, Andreas. 2024. Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice. In Scientific reports, 14, 2061. doi:10.1038/s41598-024-52667-3. https://pubmed.ncbi.nlm.nih.gov/38267530/